Author: Taylor Warfield, Former Bain Manager and interviewer

Last Updated: September 13, 2026

 

LEK exit opportunities are strongest in private equity, corporate strategy, and life sciences, and most consultants make the jump between their second and fifth year at the firm. This guide covers the eight most common exit paths, the right time to leave at each level, and what L.E.K.'s due diligence work actually does to your resume.

 

Before reading on:

 

Most candidates struggle to land interviews and even fewer turn them into offers. Watch my free training to learn how to triple your chances of landing interviews and increase your chances of receiving an offer by 8x.

 

👉 Watch for free

 

Key Takeaways

 

LEK exits cluster around private equity and life sciences because the firm's commercial due diligence work puts consultants in front of investors and biotech clients from the start.

 

• Private equity is the single most common exit, driven by L.E.K.'s 1,000+ supported transactions per year

 

• Life sciences and biotech roles are the second lane, and they are stronger at L.E.K. than at most firms its size

 

• The best exit window for undergraduate hires is the end of the three-year Associate program

 

• L.E.K. names corporate strategy and private equity as alumni destinations on its own careers site

 

• Roughly 8,000 current and former employees sit in the alumni network, spread across 80 industries

 

• Brand recognition varies by city, so your office choice shapes your exit options more than most candidates expect

 

What Are LEK Exit Opportunities?

 

LEK exit opportunities are the roles L.E.K. Consulting alumni move into after leaving the firm, most commonly private equity, corporate strategy, biotech and pharma, and other strategy consultancies. L.E.K. runs one of the largest commercial due diligence practices in strategy consulting, which pushes more of its alumni toward investor-facing and life sciences work than a typical generalist firm would.

 

The eight destinations below account for the large majority of departures:

 

• Private equity and growth equity investing

 

• Corporate strategy and corporate development at large companies

 

• Biotech, pharma, and medtech commercial roles

 

• Healthcare providers, payers, and health tech

 

• MBB and other strategy consulting firms

 

• Startups and high-growth private companies

 

• Business school, then a post-MBA pivot

 

• Founding a company or going independent

 

The scale behind those moves is bigger than most candidates assume. According to L.E.K.'s alumni network page, roughly 8,000 current and former employees work across 80 industries in more than 70 countries. For a firm with 27 offices, that is a dense network relative to headcount.

 

Why Are LEK Exit Opportunities So Strong?

 

LEK exit opportunities are strong because the firm supports more than 1,000 transactions a year, which puts consultants in front of private equity clients within months of joining. Pair that deal flow with a life sciences practice that reaches into biotech, diagnostics, and medtech, and you get a resume that reads as investor-ready rather than vaguely analytical.

 

Five things drive the outcome:

 

• Deal exposure: L.E.K. reports supporting 1,000+ transactions and 1,200+ corporate projects annually, so due diligence reps stack up fast

 

• Sector depth: the life sciences and pharma practice gives you therapeutic area knowledge that generalist consultants cannot fake in an interview

 

• Short case cycles: diligence projects often run four to eight weeks, so you see more industries in two years than most consultants see in four

 

• Early ownership: L.E.K. staffs lean, which means Associates run real workstreams instead of formatting someone else's slides

 

• Firm support: the careers site openly frames the alumni network as a route into corporate strategy and private equity roles

 

That last point deserves attention. Most firms treat departures as a quiet fact of life, but L.E.K.'s roles page tells Associates directly that the network will help them move into corporate strategy and private equity. Firms that say this out loud tend to have alumni who pick up the phone.

 

One caveat I give every candidate I coach: the strength of a firm's exits and the strength of your exits are different questions. General consulting exit opportunities reward people who chose their projects deliberately, and L.E.K. is no exception.

 

What Are the 8 Most Common Exit Opportunities After LEK?

 

The eight paths below cover where L.E.K. alumni actually land. Private equity and life sciences dominate, but the corporate and re-recruiting lanes are larger than the internet suggests.

 

Exit path	Typical entry title	Usual timing	Best fit for
Private equity	Associate or Senior Associate	Year 2 to 5	Heavy diligence staffing, strong quant
Corporate strategy	Senior Analyst to Manager	Year 2 to 6	Anyone wanting better hours and one industry
Biotech and pharma	Commercial or BD Manager	Year 2 to 6	Life Sciences Specialists and PhDs
Healthcare services	Strategy Manager or Director	Year 3 to 7	Provider and payer case experience
MBB and strategy firms	Consultant or Associate	Year 1 to 3	People who want a bigger brand
Startups	Chief of Staff or BizOps	Year 2 to 5	Generalists who want ownership
Venture and growth equity	Associate	Year 3 to 6	Sector specialists, especially in health
Business school	MBA candidate	Year 3 to 4	Career switchers who need a reset

 

Private equity: the default exit

 

Private equity is the most common L.E.K. exit and the one the firm's work is built for. Commercial due diligence means you have already written the market growth case, the competitive position read, and the customer churn analysis that an investment committee reads before writing a check. Funds hire that experience directly because it removes six months of ramp.

 

The pay step is real. Based on Glassdoor data as of May 2026, the average total pay for a private equity associate in the United States is about $249,000, with the typical range running from roughly $189,000 to $335,000 and top earners near $430,000.

 

Set that against a mid-level LEK consulting salary and the gap is obvious. The tradeoff is that consulting pay is banded and predictable while investing pay swings with fund performance.

 

The catch is modeling. L.E.K. builds commercial cases, not LBO models, so most candidates need to teach themselves LBO mechanics before recruiting. Anyone weighing consulting vs private equity should also price in the hours, which are lumpier and often longer during live deals.

 

Start prepping 12 to 18 months before you want to move. The private equity case interview tests investment judgment and technical mechanics, which is a different exercise from the candidate-led cases you passed to get into L.E.K.

 

Corporate strategy and corporate development

 

Corporate strategy is the quietest exit and the one that suits the most people. You trade project variety for depth in a single company, and the hours usually improve by 15 to 25 hours a week. L.E.K. alumni land these roles at consumer, industrial, media, and healthcare companies the firm already serves.

 

Entry level depends on your tenure. An Associate Consultant typically enters as a senior analyst or strategy manager, while a Manager can often step in at director level. If you are torn between staying and leaving, my breakdown of corporate strategy roles walks through the tradeoffs in detail.

 

Corporate development is the adjacent option and it converts better from a diligence background. If you spent two years on buy-side diligence, an in-house M&A team is a shorter jump than a strategy team that mostly runs annual planning.

 

Biotech, pharma, and medtech

 

L.E.K.'s life sciences work is the reason many candidates join the firm in the first place. The practice spans biotech and pharmaceuticals, pharma services, diagnostics, personalized medicine, and drug delivery, which means you build actual therapeutic area fluency. Hiring managers at pharma companies screen for that fluency and discount generic strategy experience.

 

Common landing spots are commercial strategy, new product planning, business development and licensing, and market access. Titles usually start at associate director or manager depending on your degree and tenure. My guide to the healthcare consulting career path covers how these roles ladder up over a decade.

 

Medtech deserves its own mention. L.E.K. runs a dedicated medtech practice covering medical equipment, consumables, and procedure-specific devices, and device companies rarely find candidates who understand both reimbursement and procedure economics.

 

Healthcare providers, payers, and health tech

 

Provider and payer exits are a separate lane from pharma and they suit different people. L.E.K.'s healthcare services practice covers hospitals, physician practice management, behavioral health, post-acute care, and healthcare IT, which maps directly onto strategy roles inside health systems and insurers.

 

These roles skew toward operators rather than analysts. Expect to run margin improvement, network strategy, or service line growth work with real budget accountability, which is a meaningful step up from advising.

 

MBB and other strategy consulting firms

 

Plenty of L.E.K. consultants leave for a bigger consulting brand rather than a different industry. This move works best early, in years one through three, before your title starts to complicate the level mapping. Most experienced hires enter at the equivalent level or one rung below.

 

The bar is the interview, not the resume. You already cleared the LEK case interview, but MBB cases run differently, and interviewer-led formats catch people who have spent two years driving their own analysis.

 

If you want to move fast, my case interview course gets you back to interview sharpness in about a week instead of a couple of months.

 

Startups and high-growth companies

 

Startup exits appeal to consultants who want to own an outcome instead of a recommendation. Chief of staff, business operations, strategic finance, and product operations are the usual titles. The L.E.K. generalist model helps here because you have seen a dozen business models rather than one.

 

Be honest about the tradeoff. Cash compensation typically drops in year one, equity is illiquid, and the structure you are used to disappears on day one.

 

Venture capital and growth equity

 

Venture is the hardest exit on this list because seats are scarce and firms hire opportunistically. Life sciences consultants have the best odds, since therapeutics-focused funds need people who can read a clinical trial readout and a market model in the same afternoon. Growth equity is more accessible than early stage venture for a consultant profile.

 

The realistic path is sector credibility plus persistent networking, not a job posting. My comparison of consulting and venture capital covers what the day-to-day actually looks like before you commit two years to chasing it.

 

Business school and the post-MBA pivot

 

Business school is less an exit than a reset button, and L.E.K. supports it directly. The firm states that it helps Associates with MBA applications and provides career coaching and transition support, which is not standard across the industry.

 

Use the MBA when your target role is genuinely closed to you now. If you want a mega fund seat or a switch into an industry with no obvious bridge, two years and the recruiting cycle that comes with it can be worth it. If you want corporate strategy, you probably do not need the degree.

 

When Is the Best Time to Leave LEK?

 

The strongest exit window for undergraduate hires is the end of the three-year Associate program, and for post-MBA hires it sits just after the Manager promotion. Leaving before your first full promotion cycle costs you the title that does the work on your resume, and staying past Principal narrows your options to senior corporate roles.

 

Level at exit	Typical tenure	Best exits available	Main risk
Associate	1 to 2 years	Re-recruiting to another firm, startups	Reads as a bad fit rather than a choice
Associate Consultant	3 to 4 years	Private equity, corporate strategy, MBA	Recruiting overlaps with peak case load
Consultant	5 to 7 years	Corporate strategy, biotech commercial	Post-MBA pay is hard to match outside
Manager	7 to 10 years	Director roles, corporate development, operating roles	Fewer seats at each step up
Principal	10+ years	VP strategy, operating partner, general management	Narrow market, long search timelines

 

Source: L.E.K. career pages for promotion timing, plus reported tenure patterns. L.E.K. states that Consultants reach Manager in two to three years on average and Managing Director in four to six.

 

Two practical notes on timing. Private equity recruiting runs on cycles that start earlier than you expect, and biotech hiring runs on headcount rather than a calendar, so the search takes longer but the window never fully closes.

 

How Do LEK Exit Opportunities Compare to MBB?

 

L.E.K. matches MBB for private equity and life sciences exits and trails it everywhere else. The difference is not talent or rigor, it is breadth of brand recognition. A hiring manager in Boston, London, or any private equity office knows exactly what L.E.K. does, while a manager in a mid-sized market may not.

 

Dimension	L.E.K.	MBB
Private equity exits	Very strong, built on diligence volume	Very strong, built on brand and networks
Life sciences exits	Best in class for a firm this size	Strong but less specialized per consultant
Large corporate roles	Good in core sectors and cities	Strong nearly everywhere
International mobility	Varies by market	Consistent globally
Modeling skills built	Commercial models, heavy quant	Varies widely by practice
Alumni network scale	About 8,000 people	Tens of thousands per firm

 

Read that table honestly rather than defensively. If your goal is a buy-side seat or a biotech commercial role, the L.E.K. path is at least as good and arguably faster, and my breakdown of MBB exit opportunities shows how similar the destinations look at the top.

 

Against other firms in its peer group, L.E.K. sits at the strong end. Among tier 2 consulting firms, few match its transaction volume, and none pair it with a life sciences practice of the same depth.

 

Do LEK Exit Opportunities Depend on Your Office and Practice?

 

Yes, more than candidates expect. Local clients become local job offers, so the sectors your office serves quietly determine the exits you will be pitched three years from now. Boston and London carry the deepest life sciences pipelines, while Los Angeles skews toward media and consumer.

 

Your practice mix matters just as much. A consultant with eight diligence projects has a private equity story, and a consultant with eight growth strategy projects has a corporate strategy story, even though both worked at the same firm for the same three years.

 

This is why the LEK office you apply to deserves more thought than a coin flip. Pick the city whose industries you want to work in after consulting, not just the one closest to home.

 

L.E.K. also runs a six-month global office swap, plus client secondments of up to six months and externships of two to three months at a nonprofit of your choice. Secondments in particular are worth chasing, because spending half a year inside a client is the closest thing to a paid audition.

 

What Do Life Sciences Specialists and PhDs Exit Into?

 

Life Sciences Specialists exit into biotech and pharma commercial strategy, business development and licensing, medical affairs strategy, and healthcare investing. The combination of a PhD or MD with L.E.K. commercial training is rare enough that these candidates often skip the entry-level rung entirely.

 

L.E.K. offers the Life Sciences Specialist role to PhDs and MDs across its Americas, Europe, and Asia offices, and describes it as a fast track to Consultant. That acceleration matters for exits: reaching Consultant faster means reaching the tenure that biotech hiring managers want faster too.

 

PhD Analysts in the United States follow a similar but broader path. Their quantitative training points toward analytics-heavy strategy roles, data science leadership, and technical product roles rather than pure commercial ones.

 

How Do You Set Up a Strong Exit From LEK?

 

Your exit is decided by the projects you staff on, not the resume you write at the end. The consultants with the best options are the ones who picked a lane in year one and defended it against the staffing team for three years. Here is how to do that.

 

Tip #1: Pick your exit sector before your second staffing cycle

 

Decide early whether you want to be the diligence person, the healthcare person, or the consumer person. Staffing teams remember preferences that are specific and repeated. Vague interest gets you whatever project needs a body.

 

Tip #2: Volunteer for commercial due diligence if you want the buy side

 

Diligence work is the single highest-value staffing for private equity recruiting. Five or six diligence projects give you a portfolio you can walk through in an interview, deal by deal.

 

Tip #3: Build the technical skill L.E.K. will not teach you

 

Commercial due diligence does not include LBO modeling, so learn it on your own time. A weekend course plus a dozen practice models closes the gap that filters out most consultant candidates in technical rounds.

 

Tip #4: Keep a running deal and project log

 

Write down the client type, the question, your analysis, and the outcome after every project. Two years later you will not remember the deal size or the growth rate you calculated, and those specifics are exactly what interviewers press on.

 

Tip #5: Use the alumni network before you need it

 

Reach out to alumni in your target industry a year before you plan to move, when the conversation costs them nothing. Good networking is a slow relationship, not a request for a referral in the first message.

 

Tip #6: Translate consulting language out of your resume

 

Nobody outside consulting knows what a workstream is. Rewrite every bullet around the business outcome and the number attached to it, which is the same standard a strong consulting resume for experienced hires already meets.

 

If you want a second set of eyes before you apply, my resume review and editing service comes with unlimited revisions and a 24-hour turnaround.

 

Senior exits look different but they are real. Jon Weber spent 25 years at L.E.K. as a Senior Managing Director leading the global consumer and retail practices, then joined Crocs in July 2025 as its chief strategy and growth officer. That is the Principal and Partner version of the same move.

 

One last example of how far this path can go. Andrew Rees spent 13 years at L.E.K. in Boston, where he founded and led the retail and consumer products practice, then joined Crocs as President in June 2014 and became chief executive officer in June 2017. LEK exit opportunities are wide open if you treat your staffing choices as career decisions rather than scheduling accidents, so pick your sector now and let three years of consistent projects do the work.

 

Frequently Asked Questions

 

Are LEK exit opportunities as strong as MBB exit opportunities?

 

For private equity and life sciences roles, LEK exit opportunities are competitive with MBB. The firm supports more than 1,000 transactions a year, so a LEK consultant often has more commercial due diligence reps by year two than an MBB peer. MBB still wins on general brand recognition, which matters most for large corporate roles and international moves outside the firm's core markets.

 

How many years do most people stay at LEK before exiting?

 

Most undergraduate hires leave somewhere between year two and year four. L.E.K. structures the Associate role as a three-year training program, so the natural exit point falls at the end of that program or shortly after the promotion to Associate Consultant. Post-MBA Consultants who stay usually leave around the Manager promotion, which L.E.K. says takes two to three years on average.

 

Can you exit from LEK to private equity without an MBA?

 

Yes. Middle market and lower middle market funds hire pre-MBA consultants directly, especially those with heavy commercial due diligence experience. You will need to build financial modeling skills on your own, because L.E.K.'s due diligence work is commercial rather than LBO modeling. Mega funds are harder to reach without banking experience or an MBA.

 

What do LEK Life Sciences Specialists exit into?

 

Life Sciences Specialists most often move into biotech and pharma commercial strategy, business development, medical affairs strategy, and healthcare investing. Their PhD or MD plus L.E.K. commercial training makes them unusually strong candidates for roles that require both scientific credibility and business judgment. Venture capital and growth equity firms with a therapeutics focus also recruit from this group.

 

Does LEK help consultants leave the firm?

 

Yes, and the firm is explicit about it. L.E.K.'s own careers site says its alumni network helps people transition out of consulting into corporate strategy and private equity roles, and it offers MBA application support plus career coaching. The firm also runs client secondments of up to six months, which sometimes convert into full-time offers.

 

Is LEK a good firm to join if you want to work in biotech?

 

It is one of the strongest options in strategy consulting. L.E.K. runs a large life sciences and pharma practice covering biotech, drug delivery, diagnostics, and medtech, so you build real therapeutic area knowledge rather than generic strategy skills. That specificity is what biotech hiring managers screen for.

 

Everything You Need to Land a Consulting Offer

 

Need help passing your interviews?

• Case Interview Course: Become a top 10% case interview candidate in 7 days while saving yourself 100+ hours
  
  
• Fit Interview Course: Master 98% of consulting fit interview questions in a few hours
  
  
• Interview Coaching: Accelerate your prep with 1-on-1 coaching with Taylor Warfield, former Bain interviewer and best-selling author

 

Need help landing interviews?

• Resume Review & Editing: Craft the perfect resume with unlimited revisions and 24-hour turnaround

 

Need help with everything?

• Consulting Offer Program: Go from zero to offer-ready with a complete system

 

Not sure where to start?

• Free 40-Minute Training: Triple your chances of landing consulting interviews and 8x your chances of passing them